2025

2025

• Study on the mechanism of 17-Hydroxy-jolkinolide B on anaplastic thyroid cancer cell.
  Yang L, Shi W, Li D, Shen Y, Li N, Meng Z.
  Am J Med Sci. 2025 Mar;369(3):405-412.
• Piperazine-based P2X4 receptor antagonists.
  Erlitz KS, Siutkina AI, Prinz AK, Koch O, Kalinin DV, Junker A.
  Arch Pharm (Weinheim). 2025 Jan;358(1):e2400860.
• Phenol (bio)isosteres in drug design and development.
  Dunker C, Schlegel K, Junker A.
  Arch Pharm (Weinheim). 2025 Jan;358(1):e2400700.
• 2-[18F]F-p-Aminobenzoic Acid Specifically Detects Infective Endocarditis in Positron Emission Tomography.
  Schulte J, Maurer A, Domogalla LC, Steinacker N, Wadle C, Kinzler J, Eder M, von Zur Mühlen C, Krohn-Grimberghe M, Eder AC.
  Infect Dis. 2025 Mar 17;231(3):e536-e544.
• A digital twin of the Biograph Vision Quadra long axial field of view PET/CT: Monte Carlo simulation and image reconstruction framework.
  Pommranz CM, Elmoujarkach EA, Lan W, Cabello J, Linder PM, Vo HP, Mannheim JG, Santangelo A, Conti M, la Fougère C, Rafecas M, Schmidt FP.
  EJNMMI Phys. 2025 Mar 31;12(1):31.
• Metabolic PCTA-Based Shift Reagents for the Detection of Extracellular Lactate Using CEST MRI.
  Chiaffarelli R, Cruz PF, Cotton J, Kelm T, Lee S, Ghaderian M, Zimmermann M, Geraldes CFGC, Jurek P, Martins AF.
  JACS Au. 2025 Feb 10;5(2):779-790.
• Optimizing stroke lesion segmentation: A dual-approach using Gaussian mixture models and nnU-Net.
  Mannel A, Khunt D, Agrawal V, Schelling K, Calderón E, la Fougère C, Castaneda-Vega S.
  Comput Biol Med. 2025 Jun;192(Pt A):110221.
• Low-activity [18F]-somatostatin receptor (SSTR) imaging using [18F]SiTATE on a long axial field-of-view PET/CT scanner.
  Trautwein NF, Calderón E, Linder PM, Reischl G, Driessen P, Lan W, Brendlin AS, Groß T, Dittmann H, Hinterleitner M, Fougère C, Schmidt FP, Kiefer LS.
  EJNMMI Phys. 2025 Feb 5;12(1):13.
• One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging.
  Calderón E, Kiefer LS, Schmidt FP, Lan W, Brendlin AS, Reinert CP, Singer S, Reischl G, Hinterleitner M, Dittmann H, la Fougère C, Trautwein NF.
  Eur J Nucl Med Mol Imaging. 2025 Jun;52(7):2463-2476.
• Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.
  Peeters E, van Genugten EAJ, Heskamp S, de Vries IJM, van Herpen C, Koenen HJPM, Kneilling M, van der Post RS, van Dop WA, Westdorp H, Aarntzen E.
  J Immunother Cancer. 2025 May 7;13(5):e011009.
• 68Ga-Labeled Glycopeptides as Effective Tools for Liver Function Imaging.
  Zierke MA, Rangger C, Samadikhah K, Schmid AM, Haubner R.
  Mol Pharm. 2025 Mar 3;22(3):1677-1685.
• Longitudinal lipoprotein and inflammatory mediators analysis uncover persisting inflammation and hyperlipidemia following SARS-CoV-2 infection in long COVID-19.
  Bae G, Yang Z, Bucci D, Wegner C, Schäfer H, Singh Y, Lonati C, Trautwein C.
  Metabolomics. 2025 May 7;21(3):65.
• Impact of Mechanical Ventilation and Anesthesia on PET Tracer Kinetics for Combined PET/fMRI Studies in Rats
  Ma Y, Kuebler L, Haas S, Maurer A, Herfert K.
  Mol Imaging Biol. 2025 May 14.
• n vivo molecular imaging of breast cancer metabolic heterogeneity using [1-13C]pyruvate-d3 hyperpolarized by reversible exchange with parahydrogen.
  Petersen S, Nagel L, Groß PR, de Maissin H, Willing R, Heß L, Mitschke J, Klemm N, Treiber J, Müller CA, Knecht S, Schwartz I, Weigt M, Bock M, von Elverfeldt D, Zaitsev M, Chekmenev EY, Hövener JB, Martins AF, Schilling F, Reinheckel T, Schmidt AB.
  Theranostics. 2025 Mar 3;15(9):3714-3723.
• Mapping serotonergic dynamics using drug-modulated molecular connectivity in rats.
  Ionescu TM, Amend M, Hafiz R, Maurer A, Biswal B, Wehrl HF, Herfert K.
  Elife. 2025 May 15;13:RP97864.